African-born bioengineer at UCLA develops new tuberculosis test
Your browser doesn’t support HTML5
According to the World Health Organization, 1.3 million people died from tuberculosis in 2022. The disease is fully treatable but relies on timely diagnosis. Mireille Kamariza, a molecular bioengineer from the University of California, Los Angeles, has developed a test that can detect the bacteria quickly, precisely and inexpensively. VOA’s Genia Dulot has the story.